Anti-depressant effect of hesperidin in diabetic rats

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 11, 2014, Pages 945-952

  El Marasy, Salma A ^a   Abdallah, Heba M I ^a   El Shenawy, Siham M ^a   El Khatib, Aiman S ^b   El Shabrawy, Osama A ^a   Kenawy, Sanaa A ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Anti depressant; Fluoxetine; Forced swimming test; Hesperidin; Streptozotocin

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; FLUOXETINE; GLUTATHIONE; HESPERIDIN; INTERLEUKIN 6; MALONALDEHYDE; NORADRENALIN; SEROTONIN; BIOGENIC AMINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FORCED SWIM TEST; HYPERGLYCEMIA; INFLAMMATION; MALE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; DEPRESSION; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; PSYCHOLOGY; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DIABETES MELLITUS, EXPERIMENTAL; FLUOXETINE; GLUTATHIONE; HESPERIDIN; HYPERGLYCEMIA; INFLAMMATION; INTERLEUKIN-6; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS, WISTAR; STREPTOZOCIN;

EID: 84909981752     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0281     Document Type: Article

References (66)

1. Ahmad, S.T., Arjumand, W., Nafees, S., Seth, A., Ali, N., Rashid, S., et al. 2012. Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation. Toxicol. Lett. 208(2): 149-161. doi:10.1016/j.toxlet.2011.10.023 PMID:22093918
2. American Diabetes Association. 2010Diagnosis and classification of diabetes mellitus. Diabetes Care, 33(Suppl. 1): S62-S69. doi:10.2337/diacare.27.2007.S5.
3. Antunes, M.S., Goes, A.R., Boeira, S.P., Prigol, M., and Jesse, C.R. 2014. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice. Nutrition. In press. doi:10.1016/j.nut.2014. 03.024.
4. Arentoft, A., Sweat, V., Starr, V., Oliver, S., Hassenstab, J., Bruehl, H., et al. 2009. Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism. Brain Cogn. 71(2): 147-152. doi:10.1016/j.bandc.2009.04.009 PMID:19481324.
5. Ates, O., Cayli, S.R., Yucel, N., Altinoz, E., Kocak, A., Durak, M.A., et al. 2007. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J. Clin. Neurosci. 14(3): 256-260. doi:10.1016/j.jocn.2005.12.010 PMID:17258134.
6. Balakrishnan, A., and Menon, V.P. 2006. Role of hesperidin on nicotine toxicity. Int. J. Pharmacol. 2(6): 664-669. doi:10.3923/ijp.2006.664.669.
7. Banasr, M., Dwyer, J.M., and Duman, R.S. 2011. Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr. Opin. Cell Biol. 23(6): 730-737. doi:10.1016/j.ceb.2011.09.002 PMID:21996102.
8. Barriere, D.A., Rieusset, J., Chanteranne, D., Busserolles, J., Chauvin, M.A., Chapuis, L., et al. 2012. Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization. Pain, 153(3): 553-561. doi:10.1016/j.pain.2011.11.019 PMID:22177224.
9. Blier, P., and El Mansari, M. 2013. Serotonin and beyond: therapeutics for major depression. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368(1615): 20120536. doi: 10.1098/rstb.2012.0536 PMID:23440470.
10. Champaneri, S., Wand, G.S., Malhotra, S.S., Casagrande, S.S., and Golden, S.H. 2010Biological basis of depression in adults with diabetes. Curr. Diab. Rep. 10(6): 396-405. doi:10.1007/s11892-010-0148-9 PMID:20878274.
11. Cryan, J.F., Markou, A., and Lucki, I. 2002a. Assessing anti-depressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23(5): 238-245. doi:10.1016/S0165-6147(02)02017-5 PMID:12008002.
12. Cryan, J.F., Page, M.E., and Lucki, I. 2002b. Noradrenergic lesions differentially alter the anti-depressant-like effects of reboxetine in a modified forced swim test. Eur. J. Pharmacol. 436(3): 197-205. doi:10.1016/S0014-2999(01)01628-4 PMID:11858799
13. de Morais, H., de Souza, C.P., da Silva, L.M., Ferreira, D.M., Werner, M.F., Andreatini, R., et al. 2014. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocindiabetic rats. Behav. Brain Res. 258: 52-64. doi:10.1016/j.bbr.2013.10.011 PMID:24140504.
14. Donato, F., de Gomes, M.G., Goes, A.T., Filho, C.B., Del Fabbro, L., Antunes, M.S., et al. 2014. Hesperidin exerts anti-depressant-like effects in acute and chronic treatments in mice: possible role of L-arginine-NO-cGMP pathway and BDNF levels. Brain Res. Bull. 104: 19-26. doi:10.1016/j.brainresbull.2014.03. 004 PMID:24709058.
15. Ellman, G.L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82(1): 70-77. doi:10.1016/0003-9861(59)90090-6 PMID:13650640.
16. Estrada-Camarena, E., Fernandez-Guasti, A., and Lopez-Rubalcava, C. 2006. Participation of the 5-HT1A receptor in the anti-depressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacology, 31(2): 247-255. doi:10.1038/sj.npp.1300821 PMID:16012533.
17. Fang, P., Min, W., Sun, Y., Guo, L., Shi, M., Bo, P., et al. 2014. The potential anti-depressant and antidiabetic effects of galanin system. Pharmacol. Biochem. Behav. 120: 82-87. doi:10.1016/j.pbb.2014.02.018 PMID:24582894.
18. Filho, C.B., Del Fabbro, L., de Gomes, M.G., Goes, A.T., Souza, L.C., Boeira, S.P., et al. 2013. Kappa-opioid receptors mediate the anti-depressant-like activity of hesperidin in the mouse forced swimming test. Eur. J. Pharmacol. 698(1-3): 286-291. doi:10.1016/j.ejphar.2012.11.003 PMID:23178563.
19. Gomez, R., and Barros, H.M. 2000. Ethopharmacology of the anti-depressant effect of clonazepam in diabetic rats. Pharmacol. Biochem. Behav. 66(2): 329-335. doi:10.1016/S0091-3057(00)00221-5 PMID:10880686.
20. Goodnick, P.J. 2001. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann. Clin. Psychiatry, 13(1): 31-41. doi:10.3109/10401230109147127 PMID:11465683.
21. Guo, J., Yu, C., Li, H., Liu, F., Feng, R., Wang, H., et al. 2010Impaired neural stem/progenitor cell proliferation in streptozotocin-induced and spontaneous diabetic mice. Neurosci. Res. 68(4): 329-336. doi:10.1016/j.neures.201008. 012 PMID:20832431.
22. Gupta, D., Kurhe, Y., and Radhakrishnan, M. 2014. Anti-depressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system. Physiol. Behav. 129: 73-78. doi:10.1016/j.physbeh.2014.02.036 PMID:24582678.
23. Ho, N., Balu, D.T., Hilario, M.R., Blendy, J.A., and Lucki, I. 2012. Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol. Behav. 105(3): 702-708. doi:10.1016/j.physbeh.2011.09.003 PMID:21945451.
24. Hurley, L.L., Akinfiresoye, L., Nwulia, E., Kamiya, A., Kulkarni, A.A., and Tizabi, Y. 2013. Anti-depressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF. Behav. Brain Res. 239: 27-30. doi:10.1016/j.bbr.2012.10.049 PMID:23142609.
25. Hwang, S.L., and Yen, G.C. 2008. Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. J. Agric. Food Chem. 56(3): 859-864. doi:10.1021/jf072826r PMID:18189359.
26. Ibrahim, S.S. 2008. Protective effect of hesperidin, a citrus bioflavonoid, on diabetes-induced brain damage in rats. J. Appl. Sci. Res. 4(1): 84-95.
27. Kang, M., Shin, D., Oh, J.W., Cho, C., Lee, H.J., Yoon, D.W., et al. 2005. The anti-depressant effect of Nelumbinis semen on rats under chronic mild stress induced depression-like symptoms. Am. J. Chin. Med. 33(2): 205-213. doi:10.1142/S0192415X05002874 PMID:15974480.
28. Khazaie, H., Rahimi, M., Tatari, F., Rezaei, M., Najafi, F., Tahmasian M. 2011. Treatment of depression in type 2 diabetes with fluoxetine or citalopram? Neurosciences (Riyadh), 16(1): 42-45 PMID:21206443.
29. Khoza, S., Barner, J.C., Bohman, T.M., Rascati, K., Lawson, K., and Wilson, J.P. 2012. Use of anti-depressant agents and the risk of type 2 diabetes. Eur. J. Clin. Pharmacol. 68(9): 1295-1302. doi:10.1007/s00228-011-1168-3 PMID:22120432.
30. Kino, M., Yamato, T., and Aomine, M. 2004. Simultaneous measurement of nitric oxide, blood glucose, and monoamines in the hippocampus of diabetic rat: anin vivo microdialysis study.Neurochem.Int.44(2): 65-73. doi:10.1016/S0197-0186(03)00125-6 PMID:12971908.
31. Kozisek, M.E., Middlemas, D., and Bylund, D.B. 2008. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of anti-depressant therapies. Pharmacol. Ther. 117(1): 30-51. doi:10.1016/j.pharmthera.2007.07.001 PMID:17949819.
32. Lee, K.H., Yeh, M.H., Kao, S.T., Hung, C.M., Liu, C.J., Huang, Y.Y., et al. 2010The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappaB in human hepatocellular carcinoma cells. Toxicol. Lett. 194(1-2): 42-49. doi:10.1016/j.toxlet.201001. 021 PMID:20138977.
33. Li, H., Zuo, Y.M., Lei, Y.H., Xu, R.J., and Wang, Y. 2014a. Modeling of diabetes mellitus-related depression. J. Neurophysiol. 46(1): 71-78. doi:10.1007/s11062-014-9408-7.
34. Li, J., Huang, M., and Shen, X. 2014b. The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis. J. Diabetes Complications, 28(5): 662-666. doi:10.1016/j.jdiacomp.2014.06.008 PMID:25044235.
35. Liu, D., Xie, K., Yang, X., Gu, J., Ge, L., Wang, X., et al. 2014. Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats. Behav. Brain Res. 264: 9-16. doi:10.1016/j.bbr.2014.01.039 PMID:24503118.
36. Luppino, F.S., de Wit, L.M., Bouvy, P.F., Stijnen, T., Cuijpers, P., Penninx, B.W., et al. 2010Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry, 67(3): 220-229. doi:10.1001/archgenpsychiatry.20102 PMID:20194822.
37. Mahmoud, A.M., Ashour, M.B., Abdel-Moneim, A., and Ahmed, O.M. 2012. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J. Diabetes Complications, 26(6): 483-490. doi:10.1016/j. jdiacomp.2012.06.001 PMID:22809898.
38. Miller, A.H., Maletic, V., and Raison, C.L. 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry, 65(9): 732-741. doi:10.1016/j.biopsych.2008.11.029 PMID:19150053.
39. Miller, A.H., Haroon, E., Raison, C.L., and Felger, J.C. 2013. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety, 30(4): 297-306. doi:10.1002/da.22084 PMID:23468190.
40. Navaratna, D., Guo, S.Z., Hayakawa, K., Wang, X., Gerhardinger, C., and Lo, E.H. 2011. Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes, 60(6): 1789-1796. doi:10.2337/db10-1371 PMID:21562076.
41. Noble, E.E., Billington, C.J., Kotz, C.M., and Wang, C. 2011. The lighter side of BDNF. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300(5): R1053-R1069. doi:10.1152/ajpregu.00776.2010 PMID:21346243.
42. Nutt, D.J. 2002. The neuropharmacology of serotonin and noradrenaline in depression. Int. Clin. Psychopharmacol. 17(Suppl. 1): S1-S12. doi:10.1097/00004850-200206001-00002 PMID:12369606.
43. Pagel, P., Blome, J., and Wolf, H.U. 2000. High-performance liquid chromatographic separation and measurement of various biogenic compounds possibly involved in the pathomechanism of Parkinson's disease. J. Chromatogr. B Biomed. Sci. Appl. 746(2): 297-304. doi:10.1016/S0378-4347(00)00348-0 PMID: 11076082.
44. Porsolt, R.D., Anton, G., Blavet, N., and Jalfre, M. 1978. Behavioural despair in rats: a new model sensitive to anti-depressant treatments. Eur. J. Pharmacol. 47(4): 379-391. doi:10.1016/0014-2999(78)90118-8 PMID:204499.
45. Post, R.M. 2007. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J. Psychiatr. Res. 41(12): 979-990. doi:10.1016/j. jpsychires.2006.09.009 PMID:17239400.
46. Raza, S.S., Khan, M.M., Ahmad, A., Ashafaq, M., Khuwaja, G., Tabassum, R., et al. 2011. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Res. 1420: 93-105. doi:10.1016/j.brainres.2011.08.047 PMID:21959178.
47. Reus, G.Z., Stringari, R.B., Ribeiro, K.F., Ferraro, A.K., Vitto, M.F., Cesconetto, P., et al. 2011. Ketamine plus imipramine treatment induces anti-depressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav. Brain Res. 221(1): 166-171. doi:10.1016/j. bbr.2011.02.024 PMID:21397634.
48. Ruiz-Larrea, M.B., Leal, A.M., Liza, M., Lacort, M., and de Groot, H. 1994. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids, 59(6): 383-388. doi:10.1016/0039-128X(94)90006-X PMID:7940617.
49. Seshasai, S.R., Kaptoge, S., Thompson, A., Di Angelantonio, E., Gao, P., Sarwar, N., et al. 2011. Diabetes mellitus, fasting glucose, and risk of causespecific death. N. Engl. J. Med. 364(9): 829-841. doi:10.1056/NEJMoa1008862 PMID:21366474.
50. Shi, X., Liao, S., Mi, H., Guo, C., Qi, D., Li, F., et al. 2012. Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Molecules, 17(11): 12868-12881. doi:10.3390/molecules171112868 PMID:23117428.
51. Souza, L.C., de Gomes, M.G., Goes, A.T., Del Fabbro, L., Filho, C.B., Boeira, S.P., et al. 2013. Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the anti-depressant-like effect caused by hesperidin in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 40: 103-109. doi:10.1016/j.pnpbp. 2012.09.003 PMID:22996046.
52. Stuart, M.J., and Baune, B.T. 2012. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci. Biobehav. Rev. 36(1): 658-676. doi:10.1016/j.neubiorev.2011.10.001 PMID:22020230.
53. Taliaz, D., Loya, A., Gersner, R., Haramati, S., Chen, A., and Zangen, A. 2011. Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J. Neurosci. 31(12): 4475-4483. doi:10.1523/JNEUROSCI.5725-10.2011 PMID:21430148.
54. Tembhurne, S.V., and Sakarkar, D.M. 2011. Effect of fluoxetine on an experimental model of diabetes-induced neuropathic pain perception in the rat. Indian J. Pharm. Sci. 73(6): 621-625. doi:10.4103/0250-474X.100235 PMID:23112395.
55. Thome, J., Pesold, B., Baader, M., Hu, M., Gewirtz, J.C., Duman, R.S., et al. 2001. Stress differentially regulates synaptophysin and synaptotagmin expression in hippocampus. Biol. Psychiatry, 50(10): 809-812. doi:10.1016/S0006-3223(01) 01229-X PMID:11720700.
56. Tuttle, H.A., Davis-Gorman, G., Goldman, S., Copeland, J.G., and McDonagh, P.F. 2004. Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. J. Diabetes Complications, 18(6): 343-351. doi:10.1016/S1056-8727(03)00088-6 PMID:15531184.
57. Ugochukwu, N.H., Mukes, J.D., and Figgers, C.L. 2006. Ameliorative effects of dietary caloric restriction on oxidative stress and inflammation in the brain of streptozotocin-induced diabetic rats. Clin. Chim. Acta, 370(1-2): 165-173. doi:10.1016/j.cca.2006.02.003 PMID:16546151.
58. Vidal, R., Valdizan, E.M., Mostany, R., Pazos, A., and Castro, E. 2009. Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptordependent signalling and functionality in rat brain. J. Neurochem. 110(3): 1120-1127. doi:10.1111/j.1471-4159.2009.06210.x PMID:19522734.
59. Visnagri, A., Kandhare, A.D., Chakravarty, S., Ghosh, P., and Bodhankar, S.L. 2014. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharm. Biol. 52(7): 814-828. doi:10.3109/13880209.2013.870584 PMID:24559476.
60. Wayhs, C.A., Manfredini, V., Sitta, A., Deon, M., Ribas, G., Vanzin, C., et al. 2010Protein and lipid oxidative damage in streptozotocin-induced diabetic rats submitted to forced swimming test: the insulin and clonazepam effect. Metab. Brain Dis. 25(3): 297-304. doi:10.1007/s11011-010-9211-0 PMID: 20838862.
61. Whiting, D.R., Guariguata, L., Weil, C., and Shaw, J. 2011. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 94(3): 311-321. doi:10.1016/j.diabres.2011.10.029 PMID:22079683.
62. Yamanaka, M., Tsuchida, A., Nakagawa, T., Nonomura, T., Ono-Kishino, M., Sugaru, E., et al. 2007. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice. Diabetes Obes. Metab. 9(1): 59-64. doi:10.1111/j.1463-1326.2006.00572.x PMID:17199719.
63. Yamato, T., Misumi, Y., Yamasaki, S., Kino, M., and Aomine, M. 2004. Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr. Metab. 17(3): 128-136 PMID:15334789.
64. Yang, H.L., Chen, S.C., Senthil Kumar, K.J., Yu, K.N., Lee Chao, P.D., Tsai, S.Y., et al. 2012. Anti-oxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach. J. Agric. Food Chem. 60(1): 522-532. doi:10.1021/jf2040675 PMID: 22098419.
65. Yi, L.T., Li, C.F., Zhan, X., Cui, C.C., Xiao, F., Zhou, L.P., et al. 2010Involvement of monoaminergic system in the anti-depressant-like effect of the flavonoid naringenin in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 34(7): 1223-1228. doi:10.1016/j.pnpbp.201006.024 PMID:20603175.
66. Zhao, C., Deng, W., and Gage, F.H. 2008. Mechanisms and functional implications of adult neurogenesis. Cell, 132(4): 645-660. doi:10.1016/j.cell.2008.01. 033 PMID:18295581.